Business Wire

NY-IWBI

30.11.2022 17:28:41 CET | Business Wire | Press release

Share
IWBI Launches the WELL Equity Rating to Advance Organizations and Places Where “Everyone Feels Welcome, Seen and Heard”

The International WELL Building Institute (IWBI) announced today the launch of the WELL Equity Rating, a new rating designed to help organizations act on their diversity, equity, inclusion and accessibility goals, and improve company culture and employee health. Over 30 leading organizations – including AvalonBay Communities, Canderel, Empire State Realty Trust, JLL, Overbury, Shaw Industries and the State University of New York (SUNY) College of Environmental Science and Forestry – have already enrolled in the rating, demonstrating their commitment to creating places where everyone has an equal opportunity to thrive.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221130005749/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

(Graphic: Business Wire)

By providing an evidence-based roadmap, the WELL Equity Rating empowers organizations to better address the needs of marginalized and underserved populations and take an action-oriented approach to creating equitable, people-first places. The rating includes more than 40 features spanning six action areas: user experience and feedback, responsible hiring and labor practices, health benefits and services, supportive programs and spaces, and community engagement. The rating validates an organization’s actions to advance health and well-being; celebrate diversity, equity, inclusion (DEI) and accessibility; and promote sensitivity while addressing disparities in populations that have been traditionally marginalized or underserved.

“Organizations worldwide are embracing the powerful role place can play in leveling the playing field and ensuring everyone feels welcome, seen and heard,” said Rachel Hodgdon, President and CEO, IWBI. “Many organizations have made commitments to DEI, but precious few have a roadmap for activation. The WELL Equity Rating is a transformative new offering that empowers organizations to make good on their promises— with evidence-based strategies and actions that improve and strengthen company culture, advance DEI goals and address disparities in underserved populations.”

For two years, IWBI has been collaborating with its Health Equity Advisory, learning from more than 200 participating expert Advisors from 26 countries. A prestigious group of more than 40 co-chairs led the Advisory, lending their tremendous knowledge and expertise in health equity, DEI, community building and belonging, and accessible design. The development process also included feedback and input from others with lived experience who represent the target populations prioritized by the rating. These include BIPOC (Black, Indigenous and other people of color), first-generation immigrants, LGBTQ+ individuals, primary caregivers and people who are physically disabled and/or neurodivergent.

“Equity and health go hand-in-hand. This rating is all about making equitable opportunity actionable, designing healthier places that are accessible to everyone, and delivering on the promise of a global culture of health and belonging,” said Kimberly Lewis, Executive Vice President of Equity, Engagement and Events, IWBI. “Because, as we know, equity is the very foundation to healthier, stronger and thriving organizations.”

Multiple studies show that employees in diverse and inclusive workplaces are more likely to innovate, enjoy their jobs, work harder, and ultimately stay with their employers for longer. Diverse organizations have also been found to be 1.32 times more productive and 21 percent more profitable than their peers. The WELL Equity Rating offers organizations a tangible path forward to help them follow through on their DEI commitments and transform how workplaces are designed, managed and operated to create environments where everyone can thrive and show up as their authentic selves.

Coinciding with the launch, in a show of leadership, over 30 organizations representing a variety of different sectors have already enrolled to pursue the WELL Equity Rating across over 1,000 locations.

They include:

  • AHA Consulting Engineers
  • AvalonBay Communities
  • Buro Happold
  • Canderel
  • Chinachem Agencies Limited
  • Delos LLC
  • ECOS
  • Empire State Realty Trust
  • Epsten Group
  • Full Circle Design Services
  • Ivanhoé Cambridge
  • JLL
  • Landsec
  • M Moser Associates
  • Menarco Development Corporation
  • NEO
  • Neovalue
  • Overbury
  • Resilient Buildings Group
  • Shaw Industries Group, Inc.
  • Shearman and Sterling
  • Simpson Coulter Studio
  • SUNY College of Environmental Science and Forestry
  • Sustainable Investment Group LLC (SIG) - Green Building Holdings
  • The Green Engineer
  • Tuolumne County
  • Veris Residential
  • Woonerf

Equity is a core tenet of the WELL Building Standard; the majority of the features in the WELL Equity Rating were drawn from existing WELL strategies, each backed by research that demonstrates more equitable outcomes for one or more of the target populations. With the help of the Health Equity and WELL Concept Advisories, IWBI also developed new beta features and parts to strengthen the new offering. This new designation will add to the suite of IWBI offerings that includes the WELL Health-Safety Rating and the WELL Performance Rating. Each rating can be earned as a stand-alone designation or milestone toward a place-based WELL Certification or an organization’s WELL Score.

“By driving accountability and action, the WELL Equity Rating will serve as an important tool to help organizations actualize their DEI commitments, live their values and effect lasting change,” said Dr. Angelita Scott, Director and Community Concept Lead at IWBI, who also served as principal architect of the rating. “We are so grateful to all our advisors and stakeholders from around the world with different backgrounds, expertise and lived experiences who supported this effort. It’s because of their vision, input and dedication that we were able to create a third-party verified solution that will uplift historically excluded voices, enhance ESG performance and improve organizational outcomes.”

In September, IWBI’s Governance Council, the leadership body tasked with upholding the integrity of WELL through rigorous standard development criteria, unanimously ratified the WELL Equity Rating. The Governance Council is made up of distinguished global thought leaders, doctors, public health professionals and business executives, such as Dr. Richard Carmona, the 17th U.S. Surgeon General; Cheryl Durst, President and CEO of the International Interior Design Association (IIDA); Dr. Yao Wang, Director General of the International Institute of Green Finance; Alison Omens, Chief Strategy Officer at Just Capital; Mona Naqvi, Global Head of ESG and Capital Markets Strategy at S&P Global; and Nancy Roman, President and CEO of Partnership for a Healthier America.

Here’s what some early adopters are saying about the WELL Equity Rating:

"ESF's commitment to the WELL Equity Rating was a resounding ‘yes’ as we work to improve and provide equitable access to the health and well-being of our campus. The rating will guide us in acknowledging populations that have been traditionally underrepresented and promoting inclusivity while celebrating the diversity that makes this campus so vibrant and successful," said SUNY College of Environmental Science and Forestry President Joanie Mahoney. "We appreciate IWBI's work and guidance in creating this rating and continuing to lead the way in putting people first."

"At Shaw, we strive to create a better future and a better world. A world in which we collectively value and invest in the health, well-being and success of all people AND our planet. A future that's safe and safeguarded for generations to come,” said Kellie Ballew, Vice President, Global Sustainability and Innovation, Shaw Industries. “The WELL Equity Rating aligns with that commitment and stands to provide external validation of our efforts."

"Ivanhoé Cambridge is proud to be part of the early adopters of the WELL Equity Rating. As a responsible real estate leader, we look at our spaces through both the investor and the employer lenses,” said Sunita Mahant, Head of Social Impact and Inclusion, Sustainable Investment at Ivanhoé Cambridge. “Our participation solidifies our commitment to creating inclusive spaces. When people walk into our buildings, we want them to feel a sense of belonging. This starts with our own employees – which is why we are kicking off our involvement with our own headquarters in Montréal.”

"Diversity, equity and inclusion (DE&I) sheds light on the needs and priorities of underserved and underrepresented populations who are some of the most valuable members of our community,” said Raymond Rufino, CEO of NEO. “We are still at the start of our DE&I journey but welcome the roadmap that the WELL Equity Rating provides to ensure that our organizations and spaces are safe, respectful and welcoming for each and every person. We’re excited to be an early adopter of the rating and hope many other companies join the journey."

“Green Building Holdings (GBH) together with our four business units at SIG, BlueO, GBES, and Aetos are continually evaluating our DEI efforts across the greater company,” said Beka Rund, Head of People, Green Building Holdings. “We are excited to adopt the WELL Equity Rating to compliment, measure, and evaluate our company for continual improvement. It is our goal to have an inclusive culture and to lead by example for our company and the greater industry.”

“The WELL Equity program provides proven strategies to inform and validate AHA’s commitment to our employees and prospective employees,” said Adam Jennings, Director of Energy, Sustainability & Commissioning, AHA Engineers. “The effects extend well beyond AHA through our service and the services we offer our clients and community.”

About the International WELL Building Institute

The International WELL Building Institute (IWBI) is a public benefit corporation and the world’s leading organization focused on deploying people-first places to advance a global culture of health. IWBI mobilizes its community through the administration of the WELL Building Standard (WELL) and WELL ratings, management of the WELL AP credential, the pursuit of applicable research, the development of educational resources, and advocacy for policies that promote health and well-being everywhere. More information on WELL can be found here.

International WELL Building Institute pbc is a wholly owned subsidiary of Delos Living LLC. International WELL Building Institute, IWBI, the WELL Building Standard, WELL v2, WELL Certified, WELL AP, WELL Portfolio, WELL Score, The WELL Conference, We Are WELL, the WELL Community Standard, WELL Health-Safety Rating, WELL Health-Safety Rated, WELL Equity, WELL Performance Rated, WELL Performance Rating, Works with WELL, WELL and others, and their related logos are trademarks or certification marks of International WELL Building Institute pbc in the United States and other countries.

Note to Editors:

WHAT DOES HEALTH EQUITY MEAN?

Our vision aligns with the Robert Wood Johnson Foundation’s definition of health equity where “everyone has a fair and just opportunity to be as healthy as possible.” Unlike equality, which involves giving everybody the same thing, equity “recognizes that each person has different circumstances and allocates the exact resources and opportunities needed to reach an equal outcome."

We support positive and preventative health factors in the belief that health is not just the absence of disease, but intimately bound up in a person’s ability to thrive. We recognize that people benefit from this “state of balance” resulting from optimal living in mind, body and spirit, and feel “content, connected to purpose, people and community."

Fulfilling this mission means recognizing that many health disparities are rooted in systemic conditions and social determinants—including the way workplaces are designed, managed and maintained—that impose significant health burdens on certain underserved populations. RWJF’s definition sets equitable access to health as a key outcome, while diversity and inclusion are ways of achieving that goal.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221130005749/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye